Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Farxiga (dapagliflozin) for Glycemic Control in Children Aged 10 Years and Older with Type-2 Diabetes

12 June 2024 – AstraZeneca’s Farxiga (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycaemic control...

FDA Approves Kevzara (sarilumab) for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)

  TARRYTOWN, N.Y. and CAMBRIDGE, MA, June 11, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)...

FDA Approves Almirall’s Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on Expanded Area of Face or Scalp

Almirall, a global pharmaceutical company dedicated to medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has approved...

FDA Approves Expanded Age Indication for GSK’s Arexvy, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine,...

FDA Grants Accelerated Approval to Iqirvo (elafibranor) for the Treatment of Primary Biliary Cholangitis

PARIS, FRANCE, 10 June 2024: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated...

FDA Approves Rytelo (imetelstat) for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia

(BUSINESS WIRE) June 6, 2024 -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the...

Diphtheria-Like Germ Can Be Passed Between People and Pets

The first two cases of a diphtheria-like illness being transmitted in the United States between people and their pets have been reported in Utah and Colorado. The...

Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization

For individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the risks for death and postacute sequelae of COVID-19 (PASC)...

Bidirectional Link ID'd for Change in Depressive Symptoms, Memory Change

A linear change in depressive symptoms is associated with accelerated memory change and vice versa in adults aged 50 years or older, according to a study...

GLP-1 RA Use Linked to Lower Quality of Bowel Preparation

The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among...

Lifestyle Intervention Can Improve Cognition, Function in Early Alzheimer Disease

For patients with mild cognitive impairment (MCI) or early dementia due to Alzheimer disease (AD), comprehensive lifestyle changes may improve cognition...

As Women Gain More Equality, Men Eat More Meat

In countries where gender equality is becoming more of a reality, men's meat consumption tends to rise relative to women's, a new study shows. The phenomenon...

Supreme Court Rejects Case That Would Have Curbed Access to Abortion Drug

The U.S. Supreme Court on Thursday threw out a case that aimed to curb access to the controversial abortion drug mifepristone, saying the plaintiffs who...

'Dual Mutant' Seasonal Flu Virus Could Make Some Treatments Ineffective

Two human cases of "dual mutant" strains of H1N1 flu have been reported by U.S. health officials. Unfortunately, the genetic changes appear to render...

Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity

CRANBURY, N.J., June 12, 2024. Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that modulate...

Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy Fordadistrogene Movaparvovec for Ambulatory Boys with Duchenne Muscular Dystrophy

(BUSINESS WIRE) June 12, 2024 -- Pfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled...

Male Enhancement Supplements Recalled

Integrity Products , St Louis MO is voluntarily recalling tainted lot (HGW221116) within expiry of the Ram It & To The Moon capsules to the consumer...

Taking a GLP-1 Medicine? Here's What Experts Say You Should Eat

Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements for good health, even if they’re eating less. A...

New Indication for Motpoly XR (Lacosamide Extended-Release) Capsules for Primary Generalized Tonic-Clonic Seizures (Adjunctive Treatment)

Today, the U.S. Food and Drug Administration (FDA) granted Aucta Pharmaceuticals a prior approval supplemental new drug application for the use of Motpoly...

Read more news...

Recently Added

Recently added consumer and prescribing information: Iqirvo, Rytelo, mRESVIA, Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Iqirvo Iqirvo (elafibranor) is a dual peroxisome-activated receptor (PPAR) alpha/delta (α,δ) agonist used for the treatment of patients with p...
  • Rytelo Rytelo (imetelstat) is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low- to intermediate-1...
  • mRESVIA mRESVIA is a modified RNA vaccine that may protect adults aged 60 years and older from lower respiratory tract disease caused by an RSV infection.

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development